Intravitreal Toxicity of High-Dose Etanercept
Authors:
- 1 February 2007
- journal article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 23 (1) , 57-62
Abstract
The aim of this study was to evaluate the retinal toxicity of high-dose intravitreal etanercept, a U.S. Food and Drug Administration-approved anti-inflammatory drug, in the rabbit model. Twenty (20) New Zealand albino rabbits were divided into 5 groups (n=4); eyes in each group were intravitreally injected with one of the following doses of etanercept: 125 microg, 250 microg, 500 microg, 1 mg, or 2.5 mg. One (1) eye in each animal was used for the study dose; the fellow eye was injected with buffered sterile saline as a control. All animals were examined using indirect ophthalmoscopy and slit-lamp biomicroscopy before and after intravitreal injection and at days 1, 7, and 14. Electroretinography (ERG) was performed on all animals before intravitreal injection and 14 days after injection. The animals were euthanized on day 14. Histological preparations of the enucleated eyes were examined with light microscopy for retinal toxicity. Clinical examination, histological evaluation, and ERG results of all 5 groups demonstrated no signs of retinal toxicity. Intravitreal doses as high as 2.5 mg of etanercept did not cause retinal toxicity. Intravitreal doses of up to 2.5 mg of etanercept may provide a more potent, prolonged effect than the lower doses previously recommended.Keywords
This publication has 21 references indexed in Scilit:
- Etanercept treatment in the endotoxin-induced uveitis of ratsExperimental Eye Research, 2004
- Contribution of TNF-α to Leukocyte Adhesion, Vascular Leakage, and Apoptotic Cell Death in Endotoxin-Induced Uveitis In VivoInvestigative Ophthalmology & Visual Science, 2003
- Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by MethotrexateArchives of Ophthalmology (1950), 2003
- The effect of genetic deficiency of adhesion molecules on the course of endotoxin-induced uveitisCurrent Eye Research, 1998
- The possible impact of uveitis in blindness: a literature survey.British Journal of Ophthalmology, 1996
- Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitisExperimental Eye Research, 1995
- Efficacy of antibodies to adhesion molecules, CDlla or CD18, in rabbit models of uveitisCurrent Eye Research, 1993
- Uveitis and systemic disease.British Journal of Ophthalmology, 1992
- Clinical Patterns and Associated Conditions in Chronic UveitisAmerican Journal of Ophthalmology, 1991
- Endotoxin-induced uveitis in rats as a model for human diseaseNature, 1980